Back to GUGGENHEIM CAPITAL LLC GUGGENHEIM CAPITAL LLC

AIMTAIMT
7 quarters

Position history for GUGGENHEIM CAPITAL LLCGUGGENHEIM CAPITAL LLC's holdings in AIMMUNE THERAPEUTICS INC

GUGGENHEIM CAPITAL LLC previously held 0 shares of AIMT (AIMMUNE THERAPEUTICS INC), worth $0 as of 2020-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$254,000

Total Shares Change

-11,358

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q4
Latest
Exited
0
-100.0%
$00.0%
0
2020-Q3
New
39,629
-
$1.4M0.0%
35
2020-Q1
Exited
0
-100.0%
$00.0%
0
2019-Q4
Decreased
10,008
-1.4%
$335,0000.0%
0
2019-Q3
Decreased
10,148
-8.8%
$212,0000.0%
0
2019-Q2
Decreased
11,126
-2.0%
$232,0000.0%
0
2019-Q1
New
11,358
-
$254,0000.0%
32

Other major holders of AIMT: Pentwater Capital Management LP, VICTORY CAPITAL MANAGEMENT INC, ALLIANCEBERNSTEIN L.P., Magnetar Financial LLC, Fiera Capital Corp

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used